246 related articles for article (PubMed ID: 9872539)
21. Usefulness of CEA, TPA, GICA, CA 72.4, and CA 195 in the Diagnosis of primary colorectal cancer and at its relapse.
Nicolini A; Caciagli M; Zampieri F; Ciampalini G; Carpi A; Spisni R; Colizzi C
Cancer Detect Prev; 1995; 19(2):183-95. PubMed ID: 7750106
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of CEA levels and positive cytology in peritoneal washings in patients with colorectal cancer.
Kanellos I; Zacharakis E; Kanellos D; Pramateftakis MG; Betsis D
Colorectal Dis; 2006 Jun; 8(5):436-40. PubMed ID: 16684089
[TBL] [Abstract][Full Text] [Related]
23. [The preoperative and postoperative carcinoembryonic antigen test in the diagnosis, staging, and prognosis of gastric cancer. Tumor Marker Committee, Japanese Foundation for Multidisciplinary Treatment of Cancer].
Sakamoto J; Nakazato H; Toge T; Mai M; Okura H; Kodaira S; Maetani S; Okajima K; Hattori T; Inokuchi K
Nihon Gan Chiryo Gakkai Shi; 1990 Jun; 25(6):1095-104. PubMed ID: 2204669
[TBL] [Abstract][Full Text] [Related]
24. THE Role of Preoperative carcinoembryonic antigen in recurrence of resectable colorectal carcinoma.
Khan MA; Maken RN; Nisar H; Fatima I; Khan IU; Masood M; Shahid AB
Acta Clin Croat; 2020 Jun; 59(2):216-222. PubMed ID: 33456107
[TBL] [Abstract][Full Text] [Related]
25. The role of CA-242 and CEA in surveillance following curative resection for colorectal cancer.
Hall NR; Finan PJ; Stephenson BM; Purves DA; Cooper EH
Br J Cancer; 1994 Sep; 70(3):549-53. PubMed ID: 8080745
[TBL] [Abstract][Full Text] [Related]
26. CEA monitoring in colorectal cancer. What you should know.
Fakih MG; Padmanabhan A
Oncology (Williston Park); 2006 May; 20(6):579-87; discussion 588, 594, 596 passim. PubMed ID: 16773844
[TBL] [Abstract][Full Text] [Related]
27. [Antigens (CEA and CA 19-9) in diagnosis and prognosis colorectal cancer].
Grotowski M
Pol Merkur Lekarski; 2002 Jan; 12(67):77-80. PubMed ID: 11957811
[TBL] [Abstract][Full Text] [Related]
28. An evaluation of the clinical usefulness of CEA in colorectal cancer.
Torosian MH; Daly JM
Oncology (Williston Park); 1991 May; 5(5):41-4; discussion 44, 49-50, 52-3. PubMed ID: 1832005
[TBL] [Abstract][Full Text] [Related]
29. An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer.
Moertel CG; Fleming TR; Macdonald JS; Haller DG; Laurie JA; Tangen C
JAMA; 1993 Aug; 270(8):943-7. PubMed ID: 8141873
[TBL] [Abstract][Full Text] [Related]
30. Is ultrasound superior to carcinoembryonic antigen (CEA) measurement in recurrent tumor screening of patients with colorectal carcinoma?
Stautner-Brückmann C; Schneider W; Gresser U; Richter-Turtur M; Eibl-Eibesfeld B; Zoller WG; Zöllner N
Bildgebung; 1990; 57(1-2):17-20. PubMed ID: 2271809
[TBL] [Abstract][Full Text] [Related]
31. [Influence of structured CEA determination and CT-scan to detect recurrence of colorectal cancer: results of the randomized clinical FACS study].
Reibetanz J; Germer CT
Chirurg; 2014 Jul; 85(7):642. PubMed ID: 25000931
[No Abstract] [Full Text] [Related]
32. Improved tumour marker sensitivity in detecting colorectal liver metastases by combined type IV collagen and CEA measurement.
Nyström H; Tavelin B; Björklund M; Naredi P; Sund M
Tumour Biol; 2015 Dec; 36(12):9839-47. PubMed ID: 26162539
[TBL] [Abstract][Full Text] [Related]
33. [After care in colorectal cancer].
Brunner H
Wien Med Wochenschr; 1988 Jun; 138(11-12):261-3. PubMed ID: 3176505
[TBL] [Abstract][Full Text] [Related]
34. Elevation of preoperative s-CEA concentration in stage IIA colorectal cancer can also be a high risk factor for stage II patients.
Kim CW; Yoon YS; Park IJ; Lim SB; Yu CS; Kim JC
Ann Surg Oncol; 2013 Sep; 20(9):2914-20. PubMed ID: 23760586
[TBL] [Abstract][Full Text] [Related]
35. The usefulness of CEA and/or CA19-9 in monitoring for recurrence in gastric cancer patients: a prospective clinical study.
Takahashi Y; Takeuchi T; Sakamoto J; Touge T; Mai M; Ohkura H; Kodaira S; Okajima K; Nakazato H;
Gastric Cancer; 2003; 6(3):142-5. PubMed ID: 14520526
[TBL] [Abstract][Full Text] [Related]
36. Carcinoembryonic antigen for the detection of recurrent disease following curative resection of colorectal cancer.
Wichmann MW; Lau-Werner U; Müller C; Hornung HM; Stieber P; Schildberg FW;
Anticancer Res; 2000; 20(6D):4953-5. PubMed ID: 11326645
[TBL] [Abstract][Full Text] [Related]
37. Monitoring of Serum Carcinoembryonic Antigen Levels after Curative Resection of Colon Cancer: Cutoff Values Determined according to Preoperative Levels Enhance the Diagnostic Accuracy for Recurrence.
Saito G; Sadahiro S; Kamata H; Miyakita H; Okada K; Tanaka A; Suzuki T
Oncology; 2017; 92(5):276-282. PubMed ID: 28178692
[TBL] [Abstract][Full Text] [Related]
38. Detection of occult liver metastases in colorectal cancer by measurement of biliary carcinoembryonic antigen.
Novell F; Trias M; Molina R; Filella X
Anticancer Res; 1997; 17(4A):2743-6. PubMed ID: 9252708
[TBL] [Abstract][Full Text] [Related]
39. Preoperative serum levels of the carcinoembryonic antigen in hereditary non-polyposis colorectal cancer compared to levels in sporadic colorectal cancer.
Schiemann U; Günther S; Gross M; Henke G; Müller-Koch Y; König A; Muders M; Folwaczny C; Mussack T; Holinski-Feder E
Cancer Detect Prev; 2005; 29(4):356-60. PubMed ID: 16122885
[TBL] [Abstract][Full Text] [Related]
40. Comparison of plasma prolactin and CEA in monitoring patients with adenocarcinoma of colon and rectum.
Bhatavdekar JM; Patel DD; Giri DD; Karelia NH; Vora HH; Ghosh N; Shah NG; Trivedi SN; Balar DB
Br J Cancer; 1992 Nov; 66(5):977-80. PubMed ID: 1419646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]